Naci, Huseyin, Cylus, Jonathan, Vandoros, Sotiris, Sato, Azusa and Perampaladas , Kumar (2012) Raising the bar for market authorisation of new drugs. BMC, 345 . e4261-e4261. ISSN 1756-1833
Abstract
Huseyin Naci and colleagues find that raising evidence standards for market entry of new drugs could have numerous benefits, including providing incentives for development in therapeutic areas with few treatment options.
| Item Type: | Article |
|---|---|
| Official URL: | http://www.bmj.com/ |
| Additional Information: | © 2012 BMJ Publishing Group Ltd. |
| Library of Congress subject classification: | R Medicine > RA Public aspects of medicine |
| Sets: | Research centres and groups > LSE Health and Social Care Research centres and groups > LSE Health Research centres and groups > ALPHA (Ageing, Lifecourse and Population Health Analysis) |
| Date Deposited: | 23 Aug 2012 15:12 |
| URL: | http://eprints.lse.ac.uk/45547/ |
Actions (login required)
 |
Record administration - authorised staff only |
